{"id":"https://openalex.org/W7123926348","doi":"https://doi.org/10.1136/jitc-2025-012706","title":"Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms","display_name":"Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7123926348","doi":"https://doi.org/10.1136/jitc-2025-012706","pmid":"https://pubmed.ncbi.nlm.nih.gov/41529908","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12815064"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2025-012706","doi":"https://doi.org/10.1136/jitc-2025-012706","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-012706","pdf_url":"https://jitc.bmj.com/content/14/1/e012706.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/1/e012706.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047456514","display_name":"Cecilia Pesini","orcid":"https://orcid.org/0000-0002-8707-2722","observed_orcids":["https://orcid.org/0000-0002-8707-2722"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]},{"id":"https://openalex.org/I4405268343","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Infecciosas","ror":"https://ror.org/00nd8zg79","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4405268343"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cecilia Pesini","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]},{"raw_affiliation_string":"CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","institution_ids":[]},{"raw_affiliation_string":"CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4405268343"]},{"raw_affiliation_string":"Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122968162","display_name":"Mario Gil-Bellido","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mario Gil-Bellido","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]},{"raw_affiliation_string":"Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089702931","display_name":"Lorena Mill\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lorena S Millan","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057717207","display_name":"Carmen O\u00f1ate","orcid":"https://orcid.org/0000-0001-6949-3462","observed_orcids":["https://orcid.org/0000-0001-6949-3462"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carmen O\u00f1ate","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]},{"raw_affiliation_string":"CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","institution_ids":[]},{"raw_affiliation_string":"Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073426429","display_name":"Adanays Calvo-P\u00e9rez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Adanays Calvo-P\u00e9rez","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]},{"raw_affiliation_string":"Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318"]},{"raw_affiliation_string":"Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084453168","display_name":"Llipsy Santiago","orcid":"https://orcid.org/0000-0002-1861-5981","observed_orcids":["https://orcid.org/0000-0002-1861-5981"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]},{"id":"https://openalex.org/I4405268343","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Infecciosas","ror":"https://ror.org/00nd8zg79","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4405268343"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Llipsy Santiago","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","Unidad de Nanotoxicolog\u00eda e Inmunotoxicolog\u00eda experimental, IIS Arag\u00f3n, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]},{"raw_affiliation_string":"CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4405268343"]},{"raw_affiliation_string":"Unidad de Nanotoxicolog\u00eda e Inmunotoxicolog\u00eda experimental, IIS Arag\u00f3n, Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034782970","display_name":"Eldris Iglesias","orcid":"https://orcid.org/0000-0003-1508-6516","observed_orcids":["https://orcid.org/0000-0003-1508-6516"]},"institutions":[{"id":"https://openalex.org/I4210121238","display_name":"Universidad San Jorge","ror":"https://ror.org/01wbg2c90","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210121238"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eldris Iglesias","raw_affiliation_strings":["Universidad San Jorge de Zaragoza, Villanueva de G\u00e1llego, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad San Jorge de Zaragoza, Villanueva de G\u00e1llego, Spain","institution_ids":["https://openalex.org/I4210121238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053691322","display_name":"Jorge Pa\u00fal Bernal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jorge Pa\u00fal Bernal","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]},{"raw_affiliation_string":"Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085683847","display_name":"Miguel Araujo\u2010Voces","orcid":"https://orcid.org/0000-0003-3360-4479","observed_orcids":["https://orcid.org/0000-0003-3360-4479"]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Araujo-Voces","raw_affiliation_strings":["Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123562239","display_name":"Laura Paz Artigas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I4405260899","display_name":"Instituto de Investigaci\u00f3n en Ingenier\u00eda de Arag\u00f3n","ror":"https://ror.org/04eqgej32","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318","https://openalex.org/I4405260899"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laura Paz Artigas","raw_affiliation_strings":["Instituto de Investigaci\u00f3n en Ingenier\u00eda de Arag\u00f3n (I3A), Universidad de Zaragoza, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n en Ingenier\u00eda de Arag\u00f3n (I3A), Universidad de Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318","https://openalex.org/I4405260899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102534007","display_name":"Laura Garcia-Martinez","orcid":"https://orcid.org/0000-0002-4293-0252","observed_orcids":["https://orcid.org/0000-0002-4293-0252"]},"institutions":[{"id":"https://openalex.org/I4210121238","display_name":"Universidad San Jorge","ror":"https://ror.org/01wbg2c90","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210121238"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laura Garc\u00eda-Mart\u00ednez","raw_affiliation_strings":["Universidad San Jorge de Zaragoza, Villanueva de G\u00e1llego, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad San Jorge de Zaragoza, Villanueva de G\u00e1llego, Spain","institution_ids":["https://openalex.org/I4210121238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070314553","display_name":"Francisco J. Roig","orcid":"https://orcid.org/0000-0002-8853-2428","observed_orcids":["https://orcid.org/0000-0002-8853-2428"]},"institutions":[{"id":"https://openalex.org/I4210121238","display_name":"Universidad San Jorge","ror":"https://ror.org/01wbg2c90","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210121238"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francisco J Roig","raw_affiliation_strings":["Biamics, Servicios de Bioinformatica SL, Zaragoza, Spain","Universidad San Jorge de Zaragoza, Villanueva de G\u00e1llego, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biamics, Servicios de Bioinformatica SL, Zaragoza, Spain","institution_ids":[]},{"raw_affiliation_string":"Universidad San Jorge de Zaragoza, Villanueva de G\u00e1llego, Spain","institution_ids":["https://openalex.org/I4210121238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072516129","display_name":"Nieves Movilla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I4405260899","display_name":"Instituto de Investigaci\u00f3n en Ingenier\u00eda de Arag\u00f3n","ror":"https://ror.org/04eqgej32","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318","https://openalex.org/I4405260899"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Nieves Movilla Meno","raw_affiliation_strings":["Instituto de Investigaci\u00f3n en Ingenier\u00eda de Arag\u00f3n (I3A), Universidad de Zaragoza, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n en Ingenier\u00eda de Arag\u00f3n (I3A), Universidad de Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318","https://openalex.org/I4405260899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121175290","display_name":"Jose Manuel Garcia-Aznar","orcid":"https://orcid.org/0000-0002-9864-7683","observed_orcids":["https://orcid.org/0000-0002-9864-7683"]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I4405260899","display_name":"Instituto de Investigaci\u00f3n en Ingenier\u00eda de Arag\u00f3n","ror":"https://ror.org/04eqgej32","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318","https://openalex.org/I4405260899"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Manuel Garcia-Aznar","raw_affiliation_strings":["Department of Mechanical Engineering, University of Zaragoza, Zaragoza, Spain","Instituto de Investigaci\u00f3n en Ingenier\u00eda de Arag\u00f3n (I3A), Universidad de Zaragoza, Zaragoza, Spain"],"raw_orcid":"https://orcid.org/0000-0002-9864-7683","affiliations":[{"raw_affiliation_string":"Department of Mechanical Engineering, University of Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318"]},{"raw_affiliation_string":"Instituto de Investigaci\u00f3n en Ingenier\u00eda de Arag\u00f3n (I3A), Universidad de Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318","https://openalex.org/I4405260899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037037350","display_name":"B\u00e1rbara Men\u00e9ndez J\u00e1ndula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"B\u00e1rbara Men\u00e9ndez-Jandula","raw_affiliation_strings":["Hematology Service, Miguel Servet University Hospital, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Service, Miguel Servet University Hospital, Zaragoza, Spain","institution_ids":["https://openalex.org/I4210114530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110935349","display_name":"Mar\u00eda Teresa Olave","orcid":"https://orcid.org/0000-0002-6326-5992","observed_orcids":["https://orcid.org/0000-0002-6326-5992"]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210135032","display_name":"Hospital Cl\u00ednico Universitario Lozano Blesa","ror":"https://ror.org/03fyv3102","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135032"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda Teresa Olave","raw_affiliation_strings":["CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","Hematology Service, Lozano Blesa University Clinical Hospital, Zaragoza, Spain","Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","Universidad de Zaragoza, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","institution_ids":[]},{"raw_affiliation_string":"Hematology Service, Lozano Blesa University Clinical Hospital, Zaragoza, Spain","institution_ids":["https://openalex.org/I4210135032"]},{"raw_affiliation_string":"Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]},{"raw_affiliation_string":"Universidad de Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016531426","display_name":"Gemma Azaceta Reinares","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210135032","display_name":"Hospital Cl\u00ednico Universitario Lozano Blesa","ror":"https://ror.org/03fyv3102","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135032"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gemma Azaceta Reinares","raw_affiliation_strings":["CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","Hematology Service, Lozano Blesa University Clinical Hospital, Zaragoza, Spain","Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","institution_ids":[]},{"raw_affiliation_string":"Hematology Service, Lozano Blesa University Clinical Hospital, Zaragoza, Spain","institution_ids":["https://openalex.org/I4210135032"]},{"raw_affiliation_string":"Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056010533","display_name":"Marta Garrote","orcid":"https://orcid.org/0000-0001-8571-1466","observed_orcids":["https://orcid.org/0000-0001-8571-1466"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marta Garrote","raw_affiliation_strings":["Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain","Hematology Department, Barcelona Clinic University Hospital, Barcelona, Spain","Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I71999127"]},{"raw_affiliation_string":"Hematology Department, Barcelona Clinic University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097"]},{"raw_affiliation_string":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000389588","display_name":"Alberto \u00c1lvarez\u2010Larr\u00e1n","orcid":"https://orcid.org/0000-0001-6387-4619","observed_orcids":["https://orcid.org/0000-0001-6387-4619"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alberto Alvarez-Larr\u00e1n","raw_affiliation_strings":["Hematology Department, Barcelona Clinic University Hospital, Barcelona, Spain","Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Barcelona Clinic University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097"]},{"raw_affiliation_string":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","institution_ids":["https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018517116","display_name":"Eva M. G\u00e1lvez","orcid":"https://orcid.org/0000-0001-6928-5516","observed_orcids":["https://orcid.org/0000-0001-6928-5516"]},"institutions":[{"id":"https://openalex.org/I134820265","display_name":"Consejo Superior de Investigaciones Cient\u00edficas","ror":"https://ror.org/02gfc7t72","country_code":"ES","type":"government","lineage":["https://openalex.org/I134820265"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210143940","display_name":"Instituto de Carboqu\u00edmica","ror":"https://ror.org/05dsysc59","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210143940"]},{"id":"https://openalex.org/I4405268343","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Infecciosas","ror":"https://ror.org/00nd8zg79","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4405268343"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eva M G\u00e1lvez","raw_affiliation_strings":["CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","CSIC, Instituto de Carboquimica, Zaragoza, Spain","Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4405268343"]},{"raw_affiliation_string":"CSIC, Instituto de Carboquimica, Zaragoza, Spain","institution_ids":["https://openalex.org/I134820265","https://openalex.org/I4210143940"]},{"raw_affiliation_string":"Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108957208","display_name":"Diego S\u00e1nchez Martinez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210085944","display_name":"Fundacion Agencia Aragonesa para la Investigacion y el Desarrollo","ror":"https://ror.org/007bpwb04","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210085944"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Diego S\u00e1nchez Mart\u00ednez","raw_affiliation_strings":["ARAID, IIS Arag\u00f3n, Zaragoza, Spain","CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARAID, IIS Arag\u00f3n, Zaragoza, Spain","institution_ids":["https://openalex.org/I4210085944","https://openalex.org/I4210136512"]},{"raw_affiliation_string":"CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","institution_ids":[]},{"raw_affiliation_string":"Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318"]},{"raw_affiliation_string":"Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112579983","display_name":"M. T. Arias","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]},{"id":"https://openalex.org/I4405268343","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Infecciosas","ror":"https://ror.org/00nd8zg79","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4405268343"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maykel A Arias","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]},{"raw_affiliation_string":"CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4405268343"]},{"raw_affiliation_string":"Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054649011","display_name":"Juli\u00e1n Pardo","orcid":"https://orcid.org/0000-0003-0154-0730","observed_orcids":["https://orcid.org/0000-0003-0154-0730"]},"institutions":[{"id":"https://openalex.org/I255234318","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28","country_code":"ES","type":"education","lineage":["https://openalex.org/I255234318"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]},{"id":"https://openalex.org/I4405268343","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Infecciosas","ror":"https://ror.org/00nd8zg79","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4405268343"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Julian Pardo","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0003-0154-0730","affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]},{"raw_affiliation_string":"CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","institution_ids":[]},{"raw_affiliation_string":"CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4405268343"]},{"raw_affiliation_string":"Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain","institution_ids":["https://openalex.org/I255234318"]},{"raw_affiliation_string":"Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068338276","display_name":"Ariel Ram\u00edrez-Labrada","orcid":"https://orcid.org/0000-0002-3888-7036","observed_orcids":["https://orcid.org/0000-0002-3888-7036"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210136512","display_name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n","ror":"https://ror.org/03njn4610","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210136512"]},{"id":"https://openalex.org/I4405268343","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Infecciosas","ror":"https://ror.org/00nd8zg79","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4405268343"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Ariel Ramirez-Labrada","raw_affiliation_strings":["Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0002-3888-7036","affiliations":[{"raw_affiliation_string":"Arag\u00f3n Health Research Institute (IIS Arag\u00f3n), Zaragoza, Spain","institution_ids":["https://openalex.org/I4210136512"]},{"raw_affiliation_string":"CERTERA, Consorcio Estatal en Red para el desarrollo de Medicamentos de Terapias Avanzadas, Carlos III, Madrid, Spain","institution_ids":[]},{"raw_affiliation_string":"CIBERINFEC, Carlos III Health Institute, Madrid, Spain, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4405268343"]},{"raw_affiliation_string":"Red RICOS de Terapias Avanzadas TERAV+, Carlos III Health Institute, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5054649011","https://openalex.org/A5068338276"],"corresponding_institution_ids":["https://openalex.org/I255234318","https://openalex.org/I2801357902","https://openalex.org/I4210136512","https://openalex.org/I4405268343"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":26.418,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.99629579,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"14","issue":"1","first_page":"e012706","last_page":"e012706"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9350000023841858},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9900000095367432},{"id":"https://openalex.org/keywords/bcr-abl1-negative-mpn","display_name":"BCR-ABL1-negative MPN","score":0.8289999961853027},{"id":"https://openalex.org/keywords/automotive-design","display_name":"automotive design","score":0.5860000252723694},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7099999785423279},{"id":"https://openalex.org/keywords/car-t-resistance","display_name":"CAR-T resistance","score":0.47999998927116394},{"id":"https://openalex.org/keywords/apoptosis-resistance","display_name":"apoptosis resistance","score":0.777999997138977},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.9549999833106995},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9819999933242798},{"id":"https://openalex.org/keywords/bh3-mimetics","display_name":"BH3 mimetics","score":0.9850000143051147},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6060000061988831},{"id":"https://openalex.org/keywords/single-cell-rna-sequencing","display_name":"single-cell RNA sequencing","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C47450691","wikidata":"https://www.wikidata.org/wiki/Q634510","display_name":"Calreticulin","level":3,"score":0.7299000024795532},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6011999845504761},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5830000042915344},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.4343000054359436},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.40959998965263367},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4002000093460083},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.37459999322891235},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.3732999861240387},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.36160001158714294},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.35350000858306885},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.35010001063346863},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3287000060081482},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.3199000060558319},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.3188000023365021},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.29660001397132874},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.29440000653266907},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.27219998836517334},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26980000734329224},{"id":"https://openalex.org/C187191949","wikidata":"https://www.wikidata.org/wiki/Q1138496","display_name":"Profiling (computer programming)","level":2,"score":0.2676999866962433},{"id":"https://openalex.org/C2910274570","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative Disorders","level":2,"score":0.25870001316070557},{"id":"https://openalex.org/C2780670749","wikidata":"https://www.wikidata.org/wiki/Q14908239","display_name":"Annexin A5","level":4,"score":0.2542000114917755},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2535000145435333}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019046","descriptor_name":"Bone Marrow Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019046","descriptor_name":"Bone Marrow Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D037282","descriptor_name":"Calreticulin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D037282","descriptor_name":"Calreticulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1136/jitc-2025-012706","doi":"https://doi.org/10.1136/jitc-2025-012706","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-012706","pdf_url":"https://jitc.bmj.com/content/14/1/e012706.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmid:41529908","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41529908","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12815064","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12815064/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmh:oai:zaguan.unizar.es:166004","doi":null,"is_oa":true,"landing_page_url":"http://zaguan.unizar.es/record/166004","pdf_url":null,"source":{"id":"https://openalex.org/S4306402461","display_name":"Zaguan (Universidad de Zaragoza)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I255234318","host_organization_name":"Universidad de Zaragoza","host_organization_lineage":["https://openalex.org/I255234318"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:digital.csic.es:10261/418999","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10261/418999","pdf_url":null,"source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:digital.csic.es:10261/425635","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10261/425635","pdf_url":null,"source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/dataset"},{"id":"pmh:oai:doaj.org/article:b240b62bf3a742f99919aba99cbb651e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b240b62bf3a742f99919aba99cbb651e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss 1 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2025-012706","doi":"https://doi.org/10.1136/jitc-2025-012706","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-012706","pdf_url":"https://jitc.bmj.com/content/14/1/e012706.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2558747001","display_name":"Individual and Collective Migration of the Immune Cellular System","funder_award_id":"101018587","funder_id":"https://openalex.org/F4320338335","funder_display_name":"H2020 European Research Council"},{"id":"https://openalex.org/G3020948319","display_name":null,"funder_award_id":"501100011033","funder_id":"https://openalex.org/F4320326208","funder_display_name":"Gobierno de Arag\u00f3n"},{"id":"https://openalex.org/G3845300180","display_name":null,"funder_award_id":"10.13039/501100011033","funder_id":"https://openalex.org/F4320326208","funder_display_name":"Gobierno de Arag\u00f3n"},{"id":"https://openalex.org/G4147089309","display_name":null,"funder_award_id":"LMP139_21","funder_id":"https://openalex.org/F4320326208","funder_display_name":"Gobierno de Arag\u00f3n"},{"id":"https://openalex.org/G567951156","display_name":"Inmunoterapia, Citotoxicidad, Inflamaci\u00f3n y C\u00e1ncer (IC)2","funder_award_id":"B29_23R","funder_id":"https://openalex.org/F4320326208","funder_display_name":"Gobierno de Arag\u00f3n"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320324111","display_name":"Universidad de Zaragoza","ror":"https://ror.org/012a91z28"},{"id":"https://openalex.org/F4320326208","display_name":"Gobierno de Arag\u00f3n","ror":"https://ror.org/0425pg203"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"},{"id":"https://openalex.org/F4320335322","display_name":"European Regional Development Fund","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320338335","display_name":"H2020 European Research Council","ror":"https://ror.org/0472cxd90"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7123926348.pdf","grobid_xml":"https://content.openalex.org/works/W7123926348.grobid-xml"},"referenced_works_count":57,"referenced_works":["https://openalex.org/W1910892394","https://openalex.org/W1983412285","https://openalex.org/W1992604276","https://openalex.org/W2014075950","https://openalex.org/W2020426144","https://openalex.org/W2039028980","https://openalex.org/W2052464502","https://openalex.org/W2052947726","https://openalex.org/W2111141291","https://openalex.org/W2135775813","https://openalex.org/W2138709799","https://openalex.org/W2143039662","https://openalex.org/W2155315999","https://openalex.org/W2157694607","https://openalex.org/W2160219845","https://openalex.org/W2173500616","https://openalex.org/W2230798701","https://openalex.org/W2306779733","https://openalex.org/W2326612786","https://openalex.org/W2531346627","https://openalex.org/W2536082432","https://openalex.org/W2545009331","https://openalex.org/W2581462115","https://openalex.org/W2731447759","https://openalex.org/W2778173016","https://openalex.org/W2795246883","https://openalex.org/W2804231581","https://openalex.org/W2804786344","https://openalex.org/W2808824118","https://openalex.org/W2892035455","https://openalex.org/W2909222910","https://openalex.org/W2913811147","https://openalex.org/W2970457608","https://openalex.org/W2990179403","https://openalex.org/W2997152681","https://openalex.org/W3016252447","https://openalex.org/W3047251097","https://openalex.org/W3138777533","https://openalex.org/W3139549049","https://openalex.org/W3196167054","https://openalex.org/W3209502886","https://openalex.org/W3215791468","https://openalex.org/W4213373081","https://openalex.org/W4224213348","https://openalex.org/W4224254421","https://openalex.org/W4283372439","https://openalex.org/W4308702374","https://openalex.org/W4313433250","https://openalex.org/W4362640714","https://openalex.org/W4365448997","https://openalex.org/W4378349149","https://openalex.org/W4385996486","https://openalex.org/W4389454314","https://openalex.org/W4390966202","https://openalex.org/W4400378045","https://openalex.org/W4402389044","https://openalex.org/W4404815641"],"related_works":["https://openalex.org/W4405043926","https://openalex.org/W7128644713","https://openalex.org/W7166847056","https://openalex.org/W4406133867","https://openalex.org/W7223133394","https://openalex.org/W7123900661","https://openalex.org/W2911491010","https://openalex.org/W2954062012","https://openalex.org/W7062516063","https://openalex.org/W7080352349"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,99,160,295],"adoptive":[2],"transfer":[3],"of":[4,40,54,162,223,231,240,245,284,341,348],"T":[5],"cells":[6,146,150,210,225,237,288,344],"engineered":[7],"to":[8,95,155,270],"express":[9],"chimeric":[10],"antigen":[11],"receptors":[12],"(CAR-T)":[13],"has":[14],"shown":[15],"high":[16,256],"efficacy":[17,115,170,253,301],"and":[18,69,91,124,134,138,147,191,211,226,234,306,316,337],"safety":[19],"in":[20,51,61,107,119,215,238,254],"treating":[21],"various":[22],"hematologic":[23,27],"malignancies.":[24],"However,":[25],"many":[26],"disorders,":[28],"such":[29,324],"as":[30,289,325],"BCR::ABL1-negative":[31],"myeloproliferative":[32],"neoplasms":[33,42],"(MPNs),":[34],"lack":[35],"effective":[36,101],"treatment":[37,347],"options.":[38],"Some":[39],"these":[41],"are":[43],"marked":[44],"by":[45,261],"a":[46,58,66,266,290,318,330],"recurrent":[47],"mutation":[48],"that":[49,88],"results":[50],"the":[52,163,185,221,278,281,346],"expression":[53],"mutant":[55],"calreticulin":[56],"(mCALR),":[57],"neoantigen":[59],"absent":[60],"healthy":[62],"tissues,":[63],"making":[64],"it":[65],"highly":[67],"specific":[68,192],"appealing":[70],"target":[71,89],"for":[72,277,293,333,345],"CAR-T":[73,97,131,169,204,224,252,287,343],"cell":[74,112,120,132,205,304],"therapy.":[75],"METHODS:":[76],"Five":[77],"distinct":[78],"CARs":[79],"were":[80,92,142,180],"designed":[81],"based":[82],"on":[83,144,168],"available":[84],"monoclonal":[85],"antibody":[86],"sequences":[87],"mCALR":[90,285],"subsequently":[93],"used":[94],"generate":[96],"cells.":[98,308],"most":[100,164],"construct":[102,297],"was":[103,116,171,259],"selected":[104],"through":[105],"functional":[106],"vitro":[108],"assays":[109,176,249],"against":[110,194,200,302],"mCALR-positive":[111],"lines.":[113],"Its":[114],"then":[117,181],"evaluated":[118],"lines,":[121],"patient-derived":[122,145,208,307],"cells,":[123,196,257],"orthotopic":[125],"xenograft":[126,216],"models,":[127,217],"assessing":[128],"tumor":[129,149,227,236],"burden,":[130],"infiltration,":[133],"animal":[135],"survival.":[136],"Bulk":[137],"single-cell":[139],"RNA":[140],"sequencing":[141],"performed":[143],"residual":[148,235],"from":[151],"CART-treated":[152],"mice,":[153],"respectively,":[154],"investigate":[156],"potential":[157],"resistance":[158,314],"mechanisms.":[159],"impact":[161],"relevant":[165],"pathway":[166],"alteration":[167],"also":[172,206],"analyzed.":[173],"Pharmacological":[174],"rescue":[175],"using":[177],"targeted":[178],"agents":[179],"conducted.":[182],"RESULTS:":[183],"Among":[184],"five":[186],"constructs,":[187],"one":[188],"demonstrated":[189],"superior":[190],"cytotoxicity":[193],"mCALR-expressing":[195],"with":[197,220,263,286,321],"no":[198],"activity":[199],"mCALR-negative":[201],"controls.":[202],"This":[203,274],"eliminated":[207],"MPN":[209],"controlled":[212],"disease":[213],"progression":[214],"which":[218,258],"correlated":[219],"persistence":[222],"infiltration.":[228],"Transcriptomic":[229],"profiling":[230,311],"patient":[232],"samples":[233],"spleens":[239],"treated":[241],"mice":[242],"revealed":[243],"upregulation":[244],"anti-apoptotic":[246],"proteins.":[247],"Functional":[248],"confirmed":[250],"reduced":[251],"Bcl-2":[255],"restored":[260],"co-treatment":[262],"venetoclax,":[264],"indicating":[265],"viable":[267],"combination":[268,319],"approach":[269],"overcome":[271],"resistance.":[272],"CONCLUSIONS:":[273],"study":[275],"demonstrates,":[276],"first":[279],"time,":[280],"successful":[282],"targeting":[283],"therapeutic":[291],"strategy":[292,320],"MPNs.":[294,349],"chosen":[296],"shows":[298],"strong":[299],"preclinical":[300,335],"established":[303],"lines":[305],"Additionally,":[309],"transcriptomic":[310],"uncovered":[312],"apoptosis":[313],"mechanisms":[315],"supports":[317],"BH3":[322],"mimetics,":[323],"venetoclax.":[326],"These":[327],"findings":[328],"provide":[329],"compelling":[331],"rationale":[332],"ongoing":[334],"development":[336],"future":[338],"clinical":[339],"application":[340],"anti-mCALR":[342]},"counts_by_year":[{"year":2026,"cited_by_count":11}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-01-14T00:00:00"}